Phillips launches next-generation Azurion image-guided therapy platform

New release offers improved level of integration across imaging, physiology, hemodynamic and informatics applications

Royal Philips has announced its next-generation Philips Azurion image-guided therapy platform, marking an important step forward in optimising clinical and operational lab performance and expanding the role of image-guided interventions in the treatment of patients.

Intuitive, integrated and efficient, the next-generation Azurion advances the capabilities of the platform to further improve the quality and efficiency of interventional procedures.

Ronald Tabaksblat, general manager for image-guided therapy systems at Philips, explains: “In the past few decades, clinical practices around the world have evolved to successfully treat more patients and perform more-complex procedures in interventional labs.

Our aim is to push the boundaries and set new industry standards for delivering an outstanding experience for clinicians, helping them to deliver superior care to every patient

“However, with more staff and technologies involved during these procedures, interventional lab environments can become crowded and cluttered.

“In order to enhance clinician focus and control during procedures, Philips has integrated all the essential lab systems and tools into this new version of the Azurion platform, making it an important step forward in lab integration.”

An industry-first, the therapy platform now integrates control of imaging, physiology, hemodynamic and informatics applications, as well as intuitive control of the gantry, at the tableside, allowing clinicians to control all compatible applications from a single touchscreen while performing procedures.

This can eliminate the need for clinicians to leave the sterile field and step into an adjacent control room, as well as supporting faster and better-informed decision making.

With this next-generation Azurion platform, Philips is also introducing a new 3D imaging solution called SmartCT, where users are guided through the image acquisition and can review and interact with the acquired CT-like 3D images on the tableside touchscreen module using 3D visualisation and measurement tools.

In order to enhance clinician focus and control during procedures, Philips has integrated all the essential lab systems and tools into this new version of the Azurion platform, making it an important step forward in lab integration

These tools have been designed to support procedures in a range of clinical domains, including neurology, oncology, and cardiovascular procedures.

The use of 3D imaging such as 3D RA or Cone Beam CT during interventional procedures has been shown to improve outcomes and reduce radiation dose for both staff and patients.

Tabaksblat said: “Our aim is to push the boundaries and set new industry standards for delivering an outstanding experience for clinicians, helping them to deliver superior care to every patient.

“This next-generation Azurion makes routine cardiovascular procedures more efficient and supports the development of new minimally-invasive techniques to treat complex diseases such as stroke, lung cancer and spine disorders.”

Companies